At Xellia Pharmaceuticals, we are highly skilled in the development and production of fermented and semi-synthetic small molecule based products. We have a strong track record manufacturing difficult-to-make Active Pharmaceutical Ingredients (APIs).
Products containing our API are sold all over the world. For more detailed information, please reach out to our Sales Team.
-
Amphotericin B
Used in the treatment of severe, invasive, potentially life-threatening fungal infections (mycosis) typically in immunocompromised patients.
View product information -
Bacitracin
Used locally for the treatment of infections of the skin, ear and eye or for intramuscular use in infants for the treatment of pneumonia and empyema caused by susceptible staphylococci in some parts of the world (e.g. Canada).
View product information -
Bacitracin zinc
Used in the treatment of local infections, mainly infections of the skin, ear and eye.
View product information -
Colistimethate sodium
Used in the treatment of acute or chronic infections due to sensitive strains of gram-negative pathogens, especially in patients with limited treatment options.
View product information -
Daptomycin
Used in the treatment of complicated skin and skin structure/soft-tissue infections caused by susceptible isolates of gram-positive bacteria in adult and pediatric patients and in the treatment of patients with Staphylococcus aureus (including MRSA-methicillin-resistant strains) bacteremia, as well as right-sided endocarditis.
View product information -
Gramicidin
Ophthalmic solution is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria, such as conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. Medicinal lozenges and spray are indicated for throat inflammatory infections. The topical cream can be used to treat certain skin infections and to prevent infections in burns, skin grafts, minor cuts and wounds. Otic solution can be used to treat infection or inflammation of the ear.
View product information -
Polymyxin B sulfate
Used in the treatment of acute urinary, meningeal or blood stream infections due to Pseudomonas aeruginosa and other gram-negative pathogens causing serious infections when less potentially toxic drugs are ineffective or contraindicated. It is often used as a combination drug product for the local treatment of skin, ear, eye and vaginal infections.
View product information -
Tobramycin sulfate
Used in the treatment of septicemia (bloodstream infection), infections of the skin, bone, lower respiratory tract, central nervous system, intra-abdominal and complicated recurrent urinary tract infections.
View product information -
Tyrothricin
Used in the treatment of local infections; mainly infections of the mouth, throat and superficial skin wounds.
View product information -
Vancomycin hydrochloride
(manufactured in Budapest, Hungary)
Used in the treatment of lower respiratory tract infections, septicemia, bone, skin and skin structure infections, and infective endocarditis due to severe systemic methicillin resistant (MRSA) and sensitive strains where other antibiotics cannot be used because of intolerance or drug resistance. May be administered orally for treating antibiotic-associated pseudomembranous colitis produced by Clostridium difficile and for staphylococcal enterocolitis.
View product information -
Vancomycin hydrochloride
(manufactured in Copenhagen, Denmark)
Used in the treatment of lower respiratory tract infections, septicemia, bone, skin and skin structure infections, and infective endocarditis due to severe systemic methicillin resistant (MRSA) and sensitive strains where other antibiotics cannot be used because of intolerance or drug resistance. May be administered orally for treating antibiotic-associated pseudomembranous colitis produced by Clostridium difficile and for staphylococcal enterocolitis.
View product information -
Vancomycin hydrochloride
(manufactured in Taizhou, China)
Used in the treatment of lower respiratory tract infections, septicemia, bone, skin and skin structure infections, and infective endocarditis due to severe systemic methicillin resistant (MRSA) and sensitive strains where other antibiotics cannot be used because of intolerance or drug resistance. May be administered orally for treating antibiotic-associated pseudomembranous colitis produced by Clostridium difficile and for staphylococcal enterocolitis.
View product information
